Systematic review and meta‐analysis of the characteristics and outcomes of readmitted COVID ‐19 survivors-Reference-Cited by-同舟云学术

Systematic review and meta‐analysis of the characteristics and outcomes of readmitted COVID ‐19 survivors

Published:2021-11 Issue:11 Volume:51 Page:1773-1780
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Subramaniam Ashwin¹²³^ORCID,Lim Zheng Jie⁴,Ponnapa Reddy Mallikarjuna¹³⁵,Shekar Kiran⁶⁷⁸

Affiliation:

1. Department of Intensive Care Medicine Peninsula Health, Frankston Hospital Melbourne Victoria Australia

2. Faculty of Medicine, Nursing and Health Sciences Monash University Melbourne Victoria Australia

3. Department of Intensive Care The Bays Hospital Melbourne Victoria Australia

4. Department of Anaesthesiology Austin Health Melbourne Victoria Australia

5. Department of Intensive Care Medicine Calvary Hospital Canberra Australian Capital Territory Australia

6. Adult Intensive Care Services The Prince Charles Hospital Brisbane Queensland Australia

7. Department of Intensive Care University of Queensland Brisbane Queensland Australia

8. Queensland University of Technology Brisbane and Bond University Gold Coast Queensland Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.15350

Reference22 articles.

1. COVID-19 and Italy: what next?

2. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

3. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

4. A scoping review of rapid review methods

5. COVID‐19 Open Access Project. Living evidence on COVID‐19. 2020. [cited 2021 February 12]. Available from URL:https://ispmbern.github.io/covid-19/living-review/

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing 30-day readmissions and outcomes in acute heart failure patients with concurrent COVID-19: A nationwide study during the 2020 pandemic;Current Problems in Cardiology;2024-02

2. Thirty-Day readmissions among COVID-19 patients hospitalized during the early pandemic in the United States: Insights from the Nationwide Readmissions Database;Heart & Lung;2023-11

3. Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial;Infectious Diseases and Therapy;2023-09

4. Autoantibodies in COVID‐19, a possible role in the pathogenesis of the disease;Therapeutic Apheresis and Dialysis;2023-05-22

5. Hospital Readmission Risk and Risk Factors of People with a Primary or Secondary Discharge Diagnosis of Diabetes;Journal of Clinical Medicine;2023-02-06